Spero Therapeutics Files 8-K on Financials
Ticker: SPRO · Form: 8-K · Filed: May 13, 2025 · CIK: 1701108
| Field | Detail |
|---|---|
| Company | Spero Therapeutics, Inc. (SPRO) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Spero Therapeutics filed an 8-K on May 13, 2025, detailing financial condition and results of operations.
AI Summary
On May 13, 2025, Spero Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Spero Therapeutics' operational and financial status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Spero Therapeutics, Inc. (company) — Registrant
- May 13, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Cambridge, Massachusetts (location) — Principal Executive Offices
FAQ
What specific financial results are reported in this 8-K filing?
The provided excerpt indicates the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
What is the primary purpose of this 8-K filing for Spero Therapeutics?
The primary purpose is to report on the company's results of operations and financial condition, along with providing financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on May 13, 2025.
Where are Spero Therapeutics' principal executive offices located?
Spero Therapeutics' principal executive offices are located at 675 Massachusetts Avenue, 14th Floor, Cambridge, Massachusetts.
What is Spero Therapeutics' standard industrial classification?
Spero Therapeutics' standard industrial classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Spero Therapeutics, Inc. (SPRO).